NEW YORK (AP) - Valeant Pharmaceuticals replaced Robert Rosiello as chief financial officer as the embattled company attempts to normalize operations amid a host of investigations and class action lawsuits.
The Canadian company named Paul Herendeen, former Zoetis chief financial officer, to fill the post immediately on Monday.
Valeant, attempting to normalize operations, names new CFO
Aucun commentaire:
Enregistrer un commentaire